Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma
- PMID: 34329660
- DOI: 10.1016/j.jhep.2021.07.016
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma
Abstract
Background & aims: The microenvironment of intrahepatic cholangiocarcinoma (iCCA) is hypovascularized, with an extensive lymphatic network. This leads to rapid cancer spread into regional lymph nodes and the liver parenchyma, precluding curative treatments. Herein, we investigated which factors released in the iCCA stroma drive the inhibition of angiogenesis and promote lymphangiogenesis.
Methods: Quantitative proteomics was performed on extracellular fluid (ECF) proteins extracted both from cancerous and non-cancerous tissues (NCT) of patients with iCCA. Computational biology was applied on a proteomic dataset to identify proteins involved in the regulation of vessel formation. Endothelial cells incubated with ECF from either iCCA or NCT specimens were used to assess the role of candidate proteins in 3D vascular assembly, cell migration, proliferation and viability. Angiogenesis and lymphangiogenesis were further investigated in vivo by a heterotopic transplantation of bone marrow stromal cells, along with endothelial cells in SCID/beige mice.
Results: Functional analysis of upregulated proteins in iCCA unveils a soluble angio-inhibitory milieu made up of thrombospondin (THBS)1, THBS2 and pigment epithelium-derived factor (PEDF). iCCA ECF was able to inhibit in vitro vessel morphogenesis and viability. Antibodies blocking THBS1, THBS2 and PEDF restored tube formation and endothelial cell viability to levels observed in NCT ECF. Moreover, in transplanted mice, the inhibition of blood vessel formation, the de novo generation of the lymphatic network and the dissemination of iCCA cells in lymph nodes were shown to depend on THBS1, THBS2 and PEDF expression.
Conclusions: THBS1, THBS2 and PEDF reduce blood vessel formation and promote tumor-associated lymphangiogenesis in iCCA. Our results identify new potential targets for interventions to counteract the dissemination process in iCCA.
Lay summary: Intrahepatic cholangiocarcinoma is a highly aggressive cancer arising from epithelial cells lining the biliary tree, characterized by dissemination into the liver parenchyma via lymphatic vessels. Herein, we show that the proteins THBS1, THBS2 and PEDF, once released in the tumor microenvironment, inhibit vascular growth, while promoting cancer-associated lymphangiogenesis. Therefore, targeting THBS1, THBS2 and PEDF may be a promising strategy to reduce cancer-associated lymphangiogenesis and counteract the invasiveness of intrahepatic cholangiocarcinoma.
Keywords: Tumor microenvironment; angiogenesis; extracellular matrix; lymphangiogenesis; proteomics.
Copyright © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest The authors of this study have no conflict of interest to declare. Please refer to the accompanying ICMJE disclosure forms for further details.
Similar articles
-
THBS1 and THBS2 Enhance the In Vitro Proliferation, Adhesion, Migration and Invasion of Intrahepatic Cholangiocarcinoma Cells.Int J Mol Sci. 2024 Feb 1;25(3):1782. doi: 10.3390/ijms25031782. Int J Mol Sci. 2024. PMID: 38339060 Free PMC article.
-
Pigment Epithelium-Derived Factor Inhibits Cell Motility and p-ERK1/2 Signaling in Intrahepatic Cholangiocarcinoma Cell Lines.Biology (Basel). 2025 Feb 3;14(2):155. doi: 10.3390/biology14020155. Biology (Basel). 2025. PMID: 40001923 Free PMC article.
-
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.J Hepatol. 2019 Apr;70(4):700-709. doi: 10.1016/j.jhep.2018.12.004. Epub 2018 Dec 14. J Hepatol. 2019. PMID: 30553841 Free PMC article.
-
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.Adv Cancer Res. 2021;149:321-387. doi: 10.1016/bs.acr.2020.10.005. Epub 2020 Dec 9. Adv Cancer Res. 2021. PMID: 33579427 Free PMC article. Review.
-
Matricellular proteins in intrahepatic cholangiocarcinoma.Adv Cancer Res. 2022;156:249-281. doi: 10.1016/bs.acr.2022.01.010. Epub 2022 Feb 18. Adv Cancer Res. 2022. PMID: 35961702 Review.
Cited by
-
Identification of Rv1133c (MetE) as a marker of Mycobacterium tuberculosis replication and as a highly immunogenic antigen with potential immunodiagnostic power.Front Immunol. 2024 Oct 4;15:1464923. doi: 10.3389/fimmu.2024.1464923. eCollection 2024. Front Immunol. 2024. PMID: 39430745 Free PMC article.
-
Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular production.Front Immunol. 2024 Jul 8;15:1375013. doi: 10.3389/fimmu.2024.1375013. eCollection 2024. Front Immunol. 2024. PMID: 39040110 Free PMC article.
-
Targeting paraptosis in cancer: opportunities and challenges.Cancer Gene Ther. 2024 Mar;31(3):349-363. doi: 10.1038/s41417-023-00722-y. Epub 2024 Jan 4. Cancer Gene Ther. 2024. PMID: 38177306 Review.
-
SERPINF1 Mediates Tumor Progression and Stemness in Glioma.Genes (Basel). 2023 Feb 25;14(3):580. doi: 10.3390/genes14030580. Genes (Basel). 2023. PMID: 36980858 Free PMC article.
-
Lymphatic vasculature in ovarian cancer.Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188950. doi: 10.1016/j.bbcan.2023.188950. Epub 2023 Jul 5. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37419192 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous